<DOC>
	<DOCNO>NCT00547300</DOCNO>
	<brief_summary>The purpose study compare tolerability nebivolol metoprolol ER populatoin patient mild moderate hypertension also receive hydrochlorothiazide ( HCTZ )</brief_summary>
	<brief_title>Study Evaluate Symptoms Patients Treated With Nebivolol Metoprolol Extended-Release ( ER ) Hypertension</brief_title>
	<detailed_description>This study 18-week study evaluate tolerability nebivolol compare metoprolol ER outpatient mild moderate hypertension take HCTZ . It multi-center , randomize , double blind ( DB ) , active-control , parallel-group study , start 4-week HCTZ run-in phase , follow 12-week DB treatment phase . Patients meet entry criterion end run-in randomize one two treatment group , nebivolol metoprolol ER . Uptitration dose study drug occur need first 4 week DB phase , 8-week stable-dose period treatment . A 2-week double-blind withdrawal phase follow , taper study drug occurs .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Male female , ambulatory outpatient 1880 yo . Females must postmenopausal , pregnant use approved contraceptive regimen History hypertension treat two medication , one must HCTZ must betablocker clonidine SBP 135155 mm Hg and/or DBP &gt; 85 mm Hg Screening Vision hearing ( hear aid permissable ) sufficient compliance test procedure ( i.e. , phone and/or internetbased assessment ) Treatment betablocker clonidine within 6 month Screening Clinically significant respiratory disease ( e.g. , bronchial asthma , reactive airway disease , chronic obstructive pulmonary disease ) Coronary artery disease require treatment calcium channel blocker nitrate Cardiovascular disease ( e.g. , myocardial infarction , cerebrovascular event , significant arrhythmia ) within 6 month screen History severe mental illness ( include Major Depressive Disorder , psychosis , dementia , bipolar disorder ) within 6 month screen Use antipsychotic medicaiton ( e.g. , dopanine receptor antagonist , serotonin dopamine receptor antagonist ) antidepressant Diabetes mellitus , type I II Participation previous investigational study nebivolol time Receipt treatment investigational study drug within 30 day screen History hypersensitivity nebivolol , metoprolol ER , betablockers , HCTZ , sulfonamidederived drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Nebivolol</keyword>
	<keyword>Beta blocker</keyword>
	<keyword>Tolerability</keyword>
</DOC>